New drug combo shows promise for rare muscle disease in kids
NCT ID NCT05524311
First seen Nov 20, 2025 · Last updated May 20, 2026 · Updated 22 times
Summary
This study tested the drug baricitinib, given with steroids, in 16 children aged 3-18 with newly diagnosed juvenile dermatomyositis, a rare disease causing muscle weakness and skin rashes. The goal was to see if baricitinib works better than the usual treatment (methotrexate plus steroids) over 24 weeks. Researchers measured improvements in muscle strength, daily function, and quality of life using a standard scale (PRINTO 20).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUVENILE DERMATOMYOSITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopital Necker - Enfants malades : unité d'immuno-hématologie et rhumatologie
Paris, France
-
Hôpital Brabois
Nancy, France
-
Hôpital Femme Mère Enfant
Bron, France
-
Hôpital Jeanne de Flandre
Lille, France
-
Hôpital La Timone
Marseille, France
-
Hôpital Necker - Enfants malades : service de dermatologie
Paris, France
-
Hôpital Pellegrin
Bordeaux, France
-
Hôpital Purpan
Toulouse, France
-
Hôpital Robert Debré
Paris, France
-
Hôpital Trousseau
Paris, France
-
Hôpital Villeneuce
Montpellier, France
-
Hôpital de Hautepierre
Strasbourg, France
-
Hôpital du Kremlin-Bicêtre
Paris, France
Conditions
Explore the condition pages connected to this study.